Monodisperse core-shell structured up-conversion Yb(OH)CO3@YbPO4:Er3+ hollow spheres as drug carriers

Biomaterials

Volumn 32, Issue 17, 2011, Pages 4161-4173

  Xu, Zhenhe ^a   Ma, Ping'an ^a   Li, Chunxia ^a   Hou, Zhiyao ^a   Zhai, Xuefeng ^a   Huang, Shanshan ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

Core shell; Doxorubicin; Drug delivery; Hydrothermal synthesis; Up conversion luminescence

Indexed keywords

ANTICANCER DRUG; CANCER CELLS; COLLOIDAL SPHERE; CORE-SHELL; DOXORUBICIN; DOXORUBICIN HYDROCHLORIDE; DRUG CARRIER; DRUG DELIVERY CARRIER; DRUG LOADING; DRUG MOLECULES; FIBROBLAST CELLS; GREEN EMISSIONS; HOLLOW SPHERE; KIRKENDALL EFFECTS; MONODISPERSE; MTT ASSAYS; RELEASE PROPERTY; SOLUTION PHASE SYNTHESIS; THERAPEUTIC EFFECTS; UP-CONVERSION; UP-CONVERSION LUMINESCENCE;

BIOCOMPATIBILITY; CELL CULTURE; CELL DEATH; CYTOTOXICITY; DRUG DELIVERY; ERBIUM; LASER EXCITATION; LOADING; LUMINESCENCE; LUMINESCENCE OF INORGANIC SOLIDS; MOLECULAR BIOLOGY; SHELLS (STRUCTURES); SPHERES; YTTERBIUM;

HYDROTHERMAL SYNTHESIS;

DOXORUBICIN; YTTERBIUM;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; COLLOID; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; PHOTOLUMINESCENCE; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HELA CELLS; HUMANS; NANOSTRUCTURES; POLYMERS; VERO CELLS;

EID: 79953273084     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.026     Document Type: Article

References (69)

1. Lou X.W., Archer L.A., Yang Z. Hollow micro-/nanostructures: synthesis and applications. Adv Mater 2008, 20:3987-4019.
2. Caruso F. Nanoengineering of particle surfaces. Adv Mater 2001, 13:11-22.
3. Gao J.H., Gu H.W., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and applications. Acc Chem Res 2009, 42:1097-1107.
4. 2 shell for removal of microcystins. J Am Chem Soc 2008, 130:28-29.
5. Zhao Y., Jiang L. Hollow micro/nanomaterials with multilevel interior structures. Adv Mater 2009, 21:3621-3638.
6. Kim S.W., Kim M., Lee W.Y., Hyeon T. Fabrication of hollow palladium spheres and their successful application to the recyclable heterogeneous catalyst for suzuki coupling reactions. J Am Chem Soc 2002, 124:7642-7643.
7. Joo S.H., Park J.Y., Tsung C.K., Yamada Y., Yang P.D., Somorjai G.A. Thermally stable Pt/mesoporous silica core-shell nanocatalysts for high-temperature reactions. Nat Mater 2009, 8:126-131.
8. Kim J., Lee J.E., Lee J., Yu J.H., Kim B.C., An K., et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc 2006, 128:688-689.
9. Lu J., Choi E., Tamanoi F., Zink J.I. Light-activated nanoimpeller-controlled drug release in cancer cells. Small 2008, 4:421-426.
10. Zhang Q., Wang W.S., Goebl J., Yin Y.D. Self-templated synthesis of hollow nanostructures. Nano Today 2009, 4:494-507.
11. Wu X.J., Xu D.S. Soft template synthesis of yolk/silica shell particles. Adv Mater 2010, 22:1516-1520.
12. Kirkendall E.O. Diffusion of zinc in alpha brass. Trans AIME 1942, 147:104-109.
13. Smigelskas A.D., Kirkendall E.O. Zinc diffusion in alpha-brass. Trans AIME 1947, 171:130-142.
14. Zhang L.H., Jia G., You H.P., Liu K., Yang M., Song Y.H., et al. Inorg Chem 2010, 49:3305-3309.
15. Yin Y.D., Rioux R.M., Erdonmez C.K., Hughes S., Somorijai G.A., Alivisatos A.P. Formation of hollow nanocrystals through the nanoscale kirkendall effect. Science 2004, 304:711-714.
16. 2 hierarchical hollow nanostructures and their application in water treatment. Adv Mater 2008, 20:452-456.
17. x reduction: anomalous stability and reactivity of a core-shell nanostructure. Angew Chem Int Ed 2005, 44:4539-4543.
18. Fan H.J., Gösele U., Zacharias M. Formation of nanotubes and hollow nanoparticles based on kirkendall and diffusion processes: a review. Small 2007, 3:1660-1671.
19. Jeong U., Wang Y., Ibisate M., Xia Y.N. Some new developments in the synthesis, functionalization, and utilization of monodisperse colloidal spheres. Adv Funct Mater 2005, 15:1907-1921.
20. Sun Y.G., Xia Y.N. Shape-controlled synthesis of gold and silver nanoparticles. Science 2002, 298:2176-2179.
21. Wang Y., Cai L., Xia Y.N. Monodisperse spherical colloids of Pb and their use as chemical templates to produce hollow particles. Adv Mater 2005, 17:473-477.
22. 2Se spherical colloids. Angew Chem Int Ed 2005, 44:3099-3103.
23. Wang F., Han Y., Lim C.S., Lu Y., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
24. Mai H.X., Zhang Y.W., Si R., Yan Z.G., Sun L.D., You L.P., et al. High-quality sodium rare-earth fluoride nanocrystals: controlled synthesis and optical properties. J Am Chem Soc 2006, 128:6426-6436.
25. Fiorenzo V., Rafik N., Venkataramanan M., Christopher M., John C. The active-core/active-shell approach: a strategy to enhance the upconversion luminescence in lanthanide-doped nanoparticles. Adv Funct Mater 2009, 19:2924-2929.
26. Wang L.Y., Yan R.X., Hao Z.Y., Wang L., Zeng J.H., Bao J., et al. Fluorescence resonant energy transfer biosensor based on upconversion-luminescent nanoparticles. Angew Chem Int Ed 2005, 44:6054-6057.
27. 3+ upconverting nanoparticles. Nanoscale 2010, 2:1417-1419.
28. Wang F., Liu X.G. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
29. Li C.X., Lin J. Rare earth fluoride nano-/microcrystals: synthesis, surface modification and application. J Mater Chem 2010, 20:6831-6847.
30. 2 nanocomposite as a drug carrier. Nanoscale 2011, 3:661-667.
31. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
32. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
33. Chatterjee D.K., Gnanasammandhan M.K., Zhang Y. Small upconverting fluorescent nanoparticles for biomedical applications. Small 2010, 6:2781-2795.
34. 3+ submicron disks assembled from primary nanocrystals. J Mater Chem 2010, 20:3178-3185.
35. Chen Z.G., Chen H.L., Hu H., Yu M.X., Li F.Y., Zhang Q., et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. J Am Chem Soc 2008, 130:3023-3029.
36. Li Z.Q., Zhang Y., Jiang S. Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv Mater 2008, 20:4765-4769.
37. 4/polymer core/shell/shell nanoparticles with significant enhancement of upconversion fluorescence. Chem Mater 2007, 19:341-343.
38. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
39. Wang F., Banerjee D., Liu Y., Chen X., Liu X. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 2010, 135:1839-1854.
40. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
41. 4 upconversion fluorescent nanocrystals. Biomaterials 2008, 30:4122-4128.
42. 4 nanocrystals in a transparent colloidal solution. Angew Chem Int Ed 2003, 42:3179-3182.
43. 4:Ln (Ln = Er or Tm) crystals in a micro reaction cell. Cryst Growth Des 2010, 10:1693-1698.
44. 4:Er crystals by naturally-derived gel growth and subsequent thermal treatment. Cryst Growth Des 2009, 9:4078-4083.
45. Matijević E., Hsu W.P. Preparation and properties of monodispersed colloidal particles of lanthanide compounds: I. Gadolinium, europium, terbium, samarium, and cerium(III). J Colloid Interface Sci 1987, 118:506-523.
46. Lechevallier S., Lecante P., Mauricot R., Dexpert H., Dexpert-Ghys J., Kong H.K., et al. Gadolinium-europium carbonate particles: controlled precipitation for luminescent biolabeling. Chem Mater 2010, 22:6153-6161.
47. Zhang F., Shi Y.F., Sun X.H., Zhao D.Y., Stucky G.D. Formation of hollow upconversion rare-earth fluoride nanospheres: nanoscale kirkendall effect during ion exchange. Chem Mater 2009, 21:5237-5243.
48. 3+ doping. J Phys Chem C 2008, 112:11707-11716.
49. 4 nano-/microstructures with tunable luminescent colors. Chem Mater 2009, 21:4598-4607.
50. 3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites. Adv Funct Mater 2008, 18:766-776.
51. 3+ hollow spheres as efficient luminescent materials and smart drug carriers. Chem Eur J 2010, 16:5672-5680.
52. Li Y., Wang Z., Huang Z., Pan Y., Xue G. A facile and environmentally friendly method for the synthesis of hollow silica particles in a self-stable dispersion. J Mater Chem 2010, 20:5516-5520.
53. Yu J., Guo H., Davis S.A., Mann S. Fabrication of hollow inorganic microspheres by chemically induced self-transformation. Adv Funct Mater 2006, 16:2035-2041.
54. Yin Y.D., Erdonmez C.K., Cabot A., Hughes S., Alivisatos A.P. Colloidal synthesis of hollow cobalt sulfide nanocrystals. Adv Funct Mater 2006, 16:1389-1399.
55. Zhu H.T., Wang J.X., Wu D.X. Fast synthesis, formation mechanism, and control of shell thickness of CuS hollow spheres. Inorg Chem 2009, 48:7099-7104.
56. 2 solid solution nanocages with controllable structures via kirkendall effect. J Am Chem Soc 2008, 130:2736-2737.
57. 3 nanorods through kirkendall diffusion. Inorg Chem 2009, 48:1334-1338.
58. 3+ nanocrystals through single laser excitation at 980 nm. Chem Eur J 2009, 15:4649-4655.
59. 3 nanomaterials as potential bioimaging probes. J Phys Chem C 2008, 112:11211-11217.
60. 3+-codoped nanocrystalline yttria: saturation and thermal effects. J Phys Chem C 2007, 111:13611-13617.
61. 4: Re (Re = Tb, Eu) multifunctional magnetic-fl{ligature}uorescent hybrid spheres for biomedical applications. Chem Commun 2010, 46:5100-5102.
62. Xiong L.Q., Chen Z.G., Yu M.X., Li F.Y., Liu C., Huang C.H. Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. Biomaterials 2009, 30:5592-5600.
63. Chen Y., Chen H., Zeng D., Tian Y., Chen F., Feng J., et al. Core/Shell structured hollow mesoporous Nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010, 4:6001-6013.
64. Huang C.C., Huang W., Yeh C.S. Shell-by-shell synthesis of multi-shelled mesoporous silica nanospheres for optical imaging and drug delivery. Biomaterials 2011, 32:556-564.
65. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997, 3:177-182.
66. Drummond D.C., Zignani M., Leroux J.C. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000, 39:409-460.
67. 3 particles and the application as anticancer drug carrier. J Am Chem Soc 2008, 130:15808-15810.
68. Blasse G., Grabmaier B.C. Luminescent materials 1994, Springer-Verlag, Berlin, Heidelberg, [chapter 4].
69. Zhao Y., Lin L.N., Lu Y., Chen S.F., Dong L., Yu S.H. Templating synthesis of preloaded doxorubicin in hollow mesoporous silica nanospheres for biomedical applications. Adv Mater 2010, 22:5255-5259.